Edition:
India

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

8.38USD
19 Jan 2018
Change (% chg)

$-0.04 (-0.48%)
Prev Close
$8.42
Open
$8.43
Day's High
$8.60
Day's Low
$8.35
Volume
5,382
Avg. Vol
11,753
52-wk High
$11.34
52-wk Low
$5.85

Select another date:

Tue, Nov 14 2017

BRIEF-Oramed receives approval for clinical study to treat NASH

* Oramed receives regulatory approval to conduct clinical study for treatment of NASH with its oral insulin capsule

BRIEF-Oramed pharmaceuticals ‍concludes its meeting with U.S. FDA regarding its oral insulin formulation​

* ‍Concluded its meeting with U.S. FDA regarding ORMD-0801, company's novel oral insulin formulation​

BRIEF-Oramed Pharmaceuticals Inc's CFO Yifat Zommer resigned from her positions with co per personal reasons

* Oramed Pharmaceuticals Inc - on July 18, yifat zommer, cfo of co resigned from her positions with co per personal reasons, effective August 1, 2017

Select another date: